Previous studies indicate that Cav1 plays a significant role in regulating both eNOS and TGF-β signaling within the vascular wall and in the development of angiotensin II (AngII)-induced abdominal aortic aneurysms (AAAs) [60,61,62,63]. The gene discussed is CAV1; the disease is achalasia-alacrima syndrome.